Role of pharmacologic enhancement of p-450 in cyclosporine overdose [1]

Transplantation

Volumn 74, Issue 9, 2002, Pages 1355-1356

  Nghiem, Dai D ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CYCLOSPORIN; CYTOCHROME P450; DILTIAZEM; ERYTHROMYCIN; FLUCONAZOLE; KETOCONAZOLE; OCTREOTIDE; PHENOBARBITAL; PHENYTOIN; TICLOPIDINE;

ADULT; AREA UNDER THE CURVE; CASE REPORT; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG METABOLISM; DRUG OVERDOSE; HUMAN; KIDNEY FAILURE; LETTER; LIVER DYSFUNCTION; MALE; NEUROTOXICITY; PRIORITY JOURNAL;

EID: 0037112886     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200211150-00027     Document Type: Letter

References (5)

1. Gonwa TA, Nghiem DD, Schulak JA, et al. Erythromycin and cyclosporine. Transplantation 1986; 41: 797.
2. DePerrot M, Spiliopoulos A, Cottons S, et al. Massive cerebral edema after IV cyclosporine overdose. Transplantation 2000; 8: 1259.
3. Arellano F, Monka C, Krupp PD. Acute cyclosporine overdose: A review of present clinical experience. Drug Safety 1991; 6: 266.
4. Kokado Y, Takahara S, Islibashi M, et al. An acute overdose of cyclosporine. Transplantation 1989; 47: 1096.
5. Jindal RM, Pescovitz MD, Cummings OW, et al. Persistence of cyclosporine after withdrawal of the drug in a patient with chronic liver transplant rejection: Role of the monoethylglycinexylidine test. Transplantation 1996; 61: 1657.11610302